Sign in

CIK 0001382574

  • Non-accelerated filer
  • Smaller reporting company

Scienture Holdings, Inc.

Sign in to watch
Ticker
SCNX
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
Phone
+1 800-261-0281
Business address
20 AUSTIN BLVD., COMMACK, NY, 11725
Former names
TRxADE HEALTH, INC, TRXADE GROUP, INC., XCELLINK INTERNATIONAL INC., Bluebird Exploration Co.
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$0
in 0 filings

Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Date Insider Transaction Shares Price Value Owned after
2026-02-20 Shankar Hariharan Co-CEO & Chairman Grant or award +500,000 3,518,679
2026-02-20 Narasimhan Mani President & Co-CEO Grant or award +500,000 1,550,000
2025-10-01 Shankar Hariharan Co-CEO & Chairman Grant or award +300,000 3,018,679
2025-10-01 Narasimhan Mani President & Co-CEO Grant or award +300,000 1,050,000
2025-04-14 Shankar Hariharan Co-CEO & Chairman Grant or award +750,000 2,718,679
2025-04-14 Narasimhan Mani President & Co-CEO Grant or award +750,000 750,000
2025-03-10 Shankar Hariharan Co-CEO & Chairman Other disposition −30,000 1,968,679
2025-03-10 Narasimhan Mani President & Co-CEO Other disposition −20,000 1,395,515
2024-09-19 Shankar Hariharan Co-CEO & Chairman Conversion +1,916,816 1,998,679
2024-09-19 Shankar Hariharan Co-CEO & Chairman Conversion +356,480 371,704
2024-09-19 Shankar Hariharan Co-CEO & Chairman Conversion · Series X Non-Voting Convertible Preferred Stock −1,916,816 0
2024-09-19 Shankar Hariharan Co-CEO & Chairman Conversion · Series X Non-Voting Convertible Preferred Stock −356,480 0
2024-09-19 Narasimhan Mani President & Co-CEO Conversion +1,357,538 1,415,515
2024-09-19 Narasimhan Mani President & Co-CEO Conversion · Series X Non-Voting Convertible Preferred Stock −1,357,538 0
2024-01-05 AJJARAPU SURENDRA K Chairman and CEO Grant or award +10,000 82,643
2024-01-05 Patel Prashant Interim CFO and Director Grant or award +10,000 112,242
2024-01-05 Patel Prashant Interim CFO and Director Grant or award +150,000 150,000
2024-01-05 AJJARAPU SURENDRA K Chairman and CEO Grant or award +150,000 150,000
2023-01-16 PETERSON MICHAEL L Director Grant or award +100,000 118,940
2023-01-16 PETERSON MICHAEL L Director Grant or award · Stock Option +135,802 135,802

Page 1 of 5 · 92 trades